Growth Hormone Increases Vascular Cell Adhesion Molecule 1 Expression: In Vivo and in Vitro Evidence

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 2, 2004, Pages 909-916

  Hansen, Troels Krarup ^a   Fisker, Sanne ^a   Dall, Rolf ^a   Ledet, Thomas ^a   Jørgensen, Jens Otto L ^a   Rasmussen, Lars Melholt ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GROWTH HORMONE; PLACEBO; SOMATOMEDIN BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTHRALGIA; ARTICLE; CELL CULTURE; CIRCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFECT; EDEMA; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MEASUREMENT; MYALGIA; PATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SOLUBILITY; STIMULATION; UMBILICAL VEIN;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLISM, INBORN ERRORS; OSMOLAR CONCENTRATION; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1442278750     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030223     Document Type: Article

References (38)

1. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111-122
2. Van den Berghe G, de Zegher F, Bouillon R 1998 Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827-1834
3. Ross RJ, Miell JP, Buchanan CR 1991 Avoiding autocannibalism. BMJ 303:1147-1148
4. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ 1999 Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785-792
5. Frystyk J, Ledet T, Moller N, Flyvbjerg A, Orskov H 2002 Cardiovascular disease and insulin-like growth factor I. Circulation 106:893-895
6. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T 2002 Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944
7. Neumann B, Engelhardt B, Wagner H, Holzmann B 1997 Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J Immunol 158:1862-1871
8. Jaeschke H, Farhood A, Smith CW 1991 Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 261(6 Pt 1):G1051-G1056
9. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Rudloff HE, Schmalstieg FC, Anderson DC 1988 Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 82:1746-1756
10. Issekutz TB, Miyasaka M, Issekutz AC 1996 Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J Exp Med 183:2175-2184
11. Read MA, Whitley MZ, Williams AJ, Collins T 1994 NF-κ B and I κ B α: an inducible regulatory system in endothelial activation. J Exp Med 179:503-512
12. Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, Ledet T 2001 Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J 360(Pt 2):363-370
13. van Oosten M, van de BE, de Vries HE, van Berkel TJ, Kuiper J 1995 Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 22:1538-1546
14. Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G 1996 Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 21:122-128
15. Leone M, Boutiere B, Camoin-Jau L, Albanese J, Horschowsky N, Mege JL, Martin C, Dignat-George F 2002 Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 30:808-814
16. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Meng X, Harken AH 2001 Vascular cell adhesion molecule-1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery 130:319-325
17. Essani NA, Bajt ML, Farhood A, Vonderfecht SL, Jaeschke H 1997 Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 158:5941-5948
18. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler III AA 1997 Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 156(2 Pt 1):431-437
19. Carraway MS, Welty-Wolf KE, Kantrow SP, Huang YC, Simonson SG, Que LG, Kishimoto TK, Piantadosi CA 1998 Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. Am J Respir Crit Care Med 157(3 Pt 1):938-949
20. Lawson JA, Burns AR, Farhood A, Lynn BM, Collins RG, Smith CW, Jaeschke H 2000 Pathophysiologic importance of E- and L-selectin for neutrophil-induced liver injury during endotoxemia in mice. Hepatology 32:990-998
21. Ridings PC, Windsor AC, Jutila MA, Blocher CR, Fisher BJ, Sholley MM, Sugerman HJ, Fowler III AA 1995 A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med 152:247-253
22. Frystyk J, Dinesen B, Orskov H 1995 Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 5:169-176
23. Knudsen ST, Foss CH, Poulsen PL, Bek T, Ledet T, Mogensen CE, Rasmussen LM 2003 E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy. Am J Physiol Endocrinol Metab 284:E1-E6
24. Edwards III CK, Lorence RM, Dunham DM, Arkins S, Yunger LM, Greager JA, Walter RJ, Dantzer R, Kelley KW 1991 Hypophysectomy inhibits the synthesis of tumor necrosis factor α by rat macrophages: partial restoration by exogenous growth hormone or interferon γ. Endocrinology 128:989-996
25. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, De Mattia G 1999 Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 34(4 Pt 1):568-573
26. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
27. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
28. Elhadd TA, Abdu TA, Oxtoby J, Kennedy G, McLaren M, Neary R, Belch JJ, Clayton RN 2001 Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab 86:4223-4232
29. Kvasnicka J, Marek J, Kvasnicka T, Weiss V, Markova M, Stepan J, Umlaufova A 2000 Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin Endocrinol (Oxf) 52:543-548
30. Fa M, Schalkwijk C, van Hinsbergh VW 2003 Distinct accumulation patterns of soluble forms of E-selectin, VCAM-1 and ICAM-1 upon infusion of TNFα in tumor patients. Thromb Haemost 89:1052-1057
31. Rasmussen LM, Schmitz O, Ledet T 2002 Increased expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured endothelial cells exposed to serum from type 1 diabetic patients: no effects of high glucose concentrations. Scand J Clin Lab Invest 62:485-493
32. Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J 2002 Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-α-induced c-Jun and NF-κB activation and adhesion molecule expression. Circ Res 90:1222-1230
33. Inoue T, Saito H, Fukushima R, Inaba T, Lin MT, Fukatsu K, Muto T 1995 Growth hormone and insulinlike growth factor 1 enhance host defense in a murine sepsis model. Arch Surg 130:1115-1122
34. Elsasser TH, Fayer R, Rumsey TS, Hartnell GF 1994 Recombinant bovine somatotropin blunts plasma tumor necrosis factor-α, cortisol, and thromboxane-B2 responses to endotoxin in vivo. Endocrinology 134:1082-1088
35. Kappel M, Hansen MB, Diamant M, Pedersen BK 1994 In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells. Horm Metab Res 26:612-614
36. Zarkesh-Esfahani SH, Kolstad O, Metcalfe RA, Watson PF, von Laue S, Walters S, Revhaug A, Weetman AP, Ross RJ 2000 High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-α, interleukin-6, and interferon-γ) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stress. J Clin Endocrinol Metab 85:3383-3390
37. Pasceri V, Willerson JT, Yeh ET 2000 Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168
38. Hansen TK, Thiel S, Dall R, Rosenfalck AM, Trainer P, Flyvbjerg A, Jorgensen JO, Christiansen JS 2001 GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I-independent immunomodulatory effect of GH. J Clin Endocrinol Metab 86:5383-5388